and antibody drug conjugate, as well as bispecific antibody approach; and Sofusa, a drug delivery technology that deliver biologic directly into the lymphatic system. Its clinical programs in ...

In May, MSD abandoned a phase 3 trial of its TIGIT drug vibostolimab, co-formulated with pembrolizumab, as an adjuvant treatment for patients with high-risk melanoma treated with surgery after a ...

A third candidate – SAB05 – is also in preclinical development and is an antibody-glucocorticoid conjugate that promises ... led by roginolisib for uveal melanoma and other oncology indications.

Fate Therapeutics (NASDAQ:FATE – Get Free Report) and BioAtla (NASDAQ:BCAB – Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two ...

A new year means a new Fierce Biotech Fundraising Tracker to record the significant amounts of venture capital being funneled into the industry. We're maintaining the criteria we used for last ...

Antibody-Drug Conjugate Found Effective Against Brain Metastases in Patients With HER2-Positive Breast Cancer Sep. 13, 2024 — A drug that delivers chemotherapy directly to tumors has shown ...

Expert Rev of Obstet Gynecol. 2012;7(3):269-279. In summary, excess levels of urobilinogen and bilirubin in the urine may signal liver disease, and more research is needed to correlate these ...

Nodular melanoma is a fast-growing, aggressive form of skin cancer that can grow into the deeper layers of the skin quickly if not removed. It is the second most common kind of melanoma. Even so, ...

Mar. 12, 2025 — A new study analyzing diet, average plasma sugar levels and cancer prevalence in some 273 vertebrate species showed surprising results. The study found no significant link ...

After hours: March 14 at 7:14:09 PM EDT Loading Chart for PDSB ...